CRSP vs SNDL · rev $11.6M vs $357.7M cap
Crispr Therapeutics AG (CRSP) versus SNDL Inc. (SNDL) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
SNDL Inc. (SNDL) is a beverages - wineries & distilleries company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
SNDL does not have a complete income-statement cache yet.
CRSP currently screens at market cap $5.42B. SNDL currently screens at market cap $357.7M.
Not investment advice. Open the CRSP and SNDL stock pages for the full models.
Not investment advice.